Health
Pfizer vaccine appears to be effective against UK coronavirus variant – BBC Focus Magazine
But when the E484K mutation – first seen in South African variant – is added, the vaccine’s effectiveness decreases.
A vaccine developed by Pfizer and BioNTech appears to be effective against the UK variant of COVID-19, according to two lab studies. But experts from the University of Cambridge found that when a mutation, known as E484K, was introduced to the variant, substantially higher levels of antibody were required to neutralise the virus.
According to the scientists, their findings, which have not yet been peer-reviewed, suggest the Pfizer/BioNtech coronavirus vaccine may be less effective when dealing with…
-
Noosa News16 hours agoWilliam Robinson dies aged 89
-
Business20 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News17 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89
-
Business21 hours agoWhat to do with these 3 ASX 200 retail shares after strong price runs: experts